Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.75
+0.19 (2.90%)
At close: May 12, 2025, 4:00 PM
6.77
+0.02 (0.30%)
After-hours: May 12, 2025, 5:42 PM EDT

Sage Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
47.441.2486.467.696.311,114
Upgrade
Revenue Growth (YoY)
-47.94%-52.30%1024.84%21.84%-99.43%16123.06%
Upgrade
Cost of Revenue
185.75235.34358.39326.98283.72293.28
Upgrade
Gross Profit
-138.35-194.1-271.94-319.29-277.41820.92
Upgrade
Selling, General & Admin
221.44216.42274.52227.7183.5196.95
Upgrade
Operating Expenses
221.44216.42274.52227.7183.5196.95
Upgrade
Operating Income
-359.78-410.52-546.46-546.99-460.91623.97
Upgrade
Interest & Investment Income
27.6931.6838.7414.192.889.6
Upgrade
Other Non Operating Income (Expenses)
0.060.03-0.380.020.130.25
Upgrade
EBT Excluding Unusual Items
-332.03-378.81-508.1-532.78-457.89633.82
Upgrade
Merger & Restructuring Charges
-22.37-21.85-33.39---27.74
Upgrade
Pretax Income
-354.4-400.67-541.49-532.78-457.89606.07
Upgrade
Net Income
-354.4-400.67-541.49-532.78-457.89606.07
Upgrade
Net Income to Common
-354.4-400.67-541.49-532.78-457.89606.07
Upgrade
Shares Outstanding (Basic)
616160595952
Upgrade
Shares Outstanding (Diluted)
616160595953
Upgrade
Shares Change (YoY)
2.08%1.55%0.89%1.08%10.69%4.27%
Upgrade
EPS (Basic)
-5.79-6.59-9.05-8.98-7.8011.66
Upgrade
EPS (Diluted)
-5.79-6.59-9.05-8.98-7.8011.43
Upgrade
Free Cash Flow
-311.09-267.19-541.14-460.97-378.55663.94
Upgrade
Free Cash Flow Per Share
-5.08-4.40-9.04-7.77-6.4512.53
Upgrade
Gross Margin
-291.84%----73.68%
Upgrade
Operating Margin
-758.97%-995.36%-632.08%-7116.69%-7306.74%56.00%
Upgrade
Profit Margin
-747.61%-971.48%-626.33%-6931.88%-7258.91%54.40%
Upgrade
Free Cash Flow Margin
-656.25%-647.85%-625.92%-5997.57%-6001.17%59.59%
Upgrade
EBITDA
-358.98-409.49-545.07-545.87-456.73626.6
Upgrade
EBITDA Margin
-----56.24%
Upgrade
D&A For EBITDA
0.811.031.391.124.182.63
Upgrade
EBIT
-359.78-410.52-546.46-546.99-460.91623.97
Upgrade
EBIT Margin
-----56.00%
Upgrade
Revenue as Reported
47.441.2486.467.696.311,114
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q